|
AU2010272957B2
(en)
*
|
2009-07-17 |
2016-03-03 |
Rigshospitalet |
Loading technique for preparing radionuclide and ionophore containing liposomes in which the ionophore is 2-hydroxyquionoline (carbostyril) or structurally related 2-hydroxyquinolines
|
|
US8822663B2
(en)
|
2010-08-06 |
2014-09-02 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DK4108671T3
(da)
|
2010-10-01 |
2025-01-06 |
Modernatx Inc |
Modificerede nukleosider, nukleotider og nukleinsyrer samt anvendelser deraf
|
|
JP2014511687A
(ja)
|
2011-03-31 |
2014-05-19 |
モデルナ セラピューティクス インコーポレイテッド |
工学操作された核酸の送達および製剤
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
JP6113737B2
(ja)
|
2011-10-03 |
2017-04-12 |
モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． |
修飾型のヌクレオシド、ヌクレオチドおよび核酸、ならびにそれらの使用方法
|
|
KR20140102759A
(ko)
|
2011-12-16 |
2014-08-22 |
모더나 세라퓨틱스, 인코포레이티드 |
변형된 뉴클레오사이드, 뉴클레오타이드 및 핵산 조성물
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
EP2834259A4
(en)
|
2012-04-02 |
2016-08-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US9597380B2
(en)
|
2012-11-26 |
2017-03-21 |
Modernatx, Inc. |
Terminally modified RNA
|
|
ES3032013T3
(en)
*
|
2013-03-15 |
2025-07-14 |
Translate Bio Inc |
Synergistic enhancement of the delivery of nucleic acids via blended formulations
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
JP2014227338A
(ja)
*
|
2013-05-17 |
2014-12-08 |
キヤノン株式会社 |
インドシアニングリーン含有粒子およびその製造方法
|
|
CA2938626A1
(en)
|
2013-07-26 |
2015-01-29 |
John Rothman |
Compositions to improve the therapeutic benefit of bisantrene
|
|
US10023626B2
(en)
|
2013-09-30 |
2018-07-17 |
Modernatx, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
EP3052521A1
(en)
|
2013-10-03 |
2016-08-10 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
WO2015166986A1
(ja)
|
2014-04-30 |
2015-11-05 |
富士フイルム株式会社 |
リポソーム組成物及びその製造方法
|
|
US10016365B2
(en)
*
|
2015-02-13 |
2018-07-10 |
Op Nano Co., Ltd. |
Compositions and methods of tumor treatment utilizing nanoparticles
|
|
CN107530291A
(zh)
|
2015-03-03 |
2018-01-02 |
奎尔波特股份有限公司 |
双重负载的脂质体药物制剂
|
|
CN107530283A
(zh)
|
2015-03-03 |
2018-01-02 |
奎尔波特股份有限公司 |
组合脂质体药物制剂
|
|
US20180243217A1
(en)
*
|
2015-03-17 |
2018-08-30 |
Leon-Nanodrugs Gmbh |
Nanoparticles comprising a stabilized boronic acid compound
|
|
WO2016161428A1
(en)
*
|
2015-04-02 |
2016-10-06 |
The Research Foundation For The State University Of New York |
Serum-stable compositions and methods for light-triggered release of materials
|
|
EP3350157B1
(en)
|
2015-09-17 |
2022-01-05 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
MA43183A
(fr)
*
|
2015-11-02 |
2018-09-12 |
Fujifilm Corp |
Agent thérapeutique antitumoral contenant une composition liposomale à base de gemcitabine et kit associé
|
|
EP3377043A4
(en)
*
|
2015-11-20 |
2019-06-26 |
The Regents of The University of California |
DEVICABLE NANOSCAL CARRIER (DNVS) FOR ADMINISTRATION THROUGH THE BLOOD-BRAIN-BARRIER, MICE AND SKIN
|
|
ES2924407T3
(es)
|
2015-12-10 |
2022-10-06 |
Modernatx Inc |
Composiciones y procedimientos para el suministro de agentes terapéuticos
|
|
US20200282101A1
(en)
*
|
2015-12-18 |
2020-09-10 |
Medigear International Corporation |
Biodegradable tumor sealant
|
|
SI3394030T1
(sl)
|
2015-12-22 |
2022-04-29 |
Modernatx, Inc. |
Sestave za doziranje sredstev v celice
|
|
KR101630397B1
(ko)
*
|
2015-12-31 |
2016-06-24 |
한국과학기술원 |
항암제-인도시아닌 그린-리포좀 복합체를 포함하는 암 치료용 조성물
|
|
US11517539B2
(en)
|
2016-02-15 |
2022-12-06 |
University Of Georgia Research Foundation, Inc. |
IPA-3-loaded liposomes and methods of use thereof
|
|
BR112018073676B1
(pt)
|
2016-05-16 |
2023-10-03 |
University Of Virginia Patent Foundation |
Lipossomas peguilados e métodos de uso
|
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
|
CN106474057A
(zh)
*
|
2016-12-02 |
2017-03-08 |
中国药科大学 |
一种奥沙利铂热敏长循环脂质体的蔗糖溶液制剂及其制备方法
|
|
SG10202107836SA
(en)
*
|
2017-01-18 |
2021-08-30 |
Temasek Life Sciences Laboratory Ltd |
Hyperstabilized liposomes increase targeting of mitotic cells
|
|
FI3596041T3
(fi)
|
2017-03-15 |
2023-01-31 |
|
Yhdiste ja koostumuksia terapeuttisten aineiden antamiseen solun sisään
|
|
JP7332478B2
(ja)
|
2017-03-15 |
2023-08-23 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子製剤
|
|
ES2911186T3
(es)
|
2017-03-15 |
2022-05-18 |
Modernatx Inc |
Formas cristalinas de aminolípidos
|
|
US12514929B2
(en)
|
2017-04-03 |
2026-01-06 |
The Regents Of The University Of California |
Deformable nano-scale vehicles (DNVS) for trans-blood brain barrier, trans-mucosal, and transdermal drug delivery
|
|
EP3638678B1
(en)
|
2017-06-14 |
2025-12-03 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of agents
|
|
US11786607B2
(en)
|
2017-06-15 |
2023-10-17 |
Modernatx, Inc. |
RNA formulations
|
|
US10925831B2
(en)
*
|
2017-08-28 |
2021-02-23 |
Wake Forest University |
Liposomal formulations of platinum-acridine anticancer agents and methods thereof
|
|
AU2018326799A1
(en)
|
2017-08-31 |
2020-02-27 |
Modernatx, Inc. |
Methods of making lipid nanoparticles
|
|
WO2019084290A1
(en)
*
|
2017-10-25 |
2019-05-02 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
COMPOSITIONS AND METHODS FOR THE ADMINISTRATION OF PHARMACEUTICAL AGENTS
|
|
US10606661B2
(en)
*
|
2017-12-15 |
2020-03-31 |
Rubrik, Inc. |
On-demand provisioning of customized developer environments
|
|
WO2019133916A1
(en)
|
2017-12-29 |
2019-07-04 |
Wayne State University |
Drug delivery systems for treatment of infections
|
|
JP7364561B2
(ja)
|
2018-06-20 |
2023-10-18 |
富士フイルム株式会社 |
ゲムシタビンを内包するリポソーム組成物および免疫チェックポイント阻害剤を含む組合せ医薬
|
|
EP4509118A3
(en)
|
2018-09-19 |
2025-05-14 |
ModernaTX, Inc. |
High-purity peg lipids and uses thereof
|
|
WO2020061284A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Peg lipids and uses thereof
|
|
EP3853202A1
(en)
|
2018-09-19 |
2021-07-28 |
ModernaTX, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
|
US12090235B2
(en)
|
2018-09-20 |
2024-09-17 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
|
EP3890775A1
(en)
*
|
2018-12-06 |
2021-10-13 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic compositions
|
|
RU2706427C1
(ru)
*
|
2018-12-27 |
2019-11-19 |
Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский технологический университет "МИСиС" |
Способ лечения онкологических заболеваний с помощью инъекций лекарственного препарата
|
|
JP7253735B2
(ja)
|
2019-07-02 |
2023-04-07 |
パナソニックＩｐマネジメント株式会社 |
通過可否判定装置、通過管理システム、通過可否判定方法、及び、コンピュータプログラム
|
|
BR112022004759A2
(pt)
|
2019-09-19 |
2022-06-21 |
Modernatx Inc |
Composições e compostos lipídicos com cauda ramificada para entrega intracelular de agentes terapêuticos
|
|
KR20220066887A
(ko)
|
2019-09-19 |
2022-05-24 |
덴마크스 텍니스케 유니버시테트 |
면역 자극 미셀 조성물
|
|
US20220364139A1
(en)
*
|
2019-09-24 |
2022-11-17 |
Pataigin, Llc |
Methods for determining growth and response
|
|
CN110571005B
(zh)
*
|
2019-09-27 |
2021-01-01 |
广西科技大学 |
一种固定化金属离子-磁性脂质体及其制备方法和应用
|
|
WO2022038605A1
(en)
*
|
2020-08-20 |
2022-02-24 |
Bionanosim (Bns) Ltd |
Lipid delivery systems for delivery of oxaliplatin palmitate acetate
|
|
KR102560135B1
(ko)
|
2020-12-04 |
2023-07-27 |
가톨릭대학교 산학협력단 |
표적 치료제의 효과적인 전달을 위한 다기능성 리포좀 조성물
|
|
WO2022171777A1
(en)
|
2021-02-12 |
2022-08-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Method for prognosis and treating a patient suffering from cancer
|
|
US11524023B2
(en)
|
2021-02-19 |
2022-12-13 |
Modernatx, Inc. |
Lipid nanoparticle compositions and methods of formulating the same
|
|
EP4306126A1
(en)
|
2021-03-08 |
2024-01-17 |
Eyegene Inc. |
Vaccine composition for preventing sars-cov-2
|